Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper ...

EDISON, N.J., Aug. 8, 2023 /CNW/ -- Brillio, a leading digital transformation services and solutions provider, today announced a partnership with Google Cloud to build cutting-edge solutions for ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

In late 2022, after the tech giant declared a “code red” over the popularity of a new AI program called ChatGPT, a small team within Google’s AI division sprinted over the Thanksgiving and Christmas ...

Alphabet-owned Isomorphic Labs says its first AI-designed drug is nearly ready for human trials, targeting diseases like cancer and heart failure. Nucleus_AI 2797 Stories Tuesday July 08, 2025 , 2 ...

It sounds like a far-fetched reality, but the use of generative artificial intelligence (AI) in healthcare is developing at a rapid pace. The most recent development is Google Cloud's announcement ...

Finally, Google says AI will empower provincial radiologists using chest X-rays by providing preliminary imaging findings. Google will also provide Nova Scotia Health professionals with in-person and ...

Google DeepMind's drug discovery company, Isomorphic Labs, is set to launch human trials of its AI-designed drugs. The company is aiming to use cutting-edge AI to design medicines faster, cheaper ...